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Objective 
Within a national quality assurance project, we previously showed central review improved clinical 
target volume (CTV) delineation for rectal cancer radiotherapy. However, 909 of the 1224 (74.2%) 
centrally reviewed CTVs needed modifications despite the availability of delineation guidelines (Roels 
et al, IJROBP 2006). This observation may point to an inaccurate description of the anatomic 
boundaries in the delineation guidelines. As a first step to clarify these guidelines, we quantified the 
modifications and identified the rectal CTV subregions at risk for divergent delineation.   
Material and Methods 
With in-house developed software, 3D surface distance analysis was performed on 896 cases that 
were modified in the review project (13 could not be analyzed due to technical problems). The 
surface of the original and modified CTV was sampled with around 10000 equally distributed dots. 
The 3D CTV was divided into eight subregions: the upper and lower border, high anterior, low 
anterior and posterior regions, high lateral region, the ischiorectal fossa, the high lateral part 
(including the iliac vessels) and the obturator region. For each subregion the maximum normal 
distance between the original and the modified CTV was calculated. Fischer’s exact testing was used 
to assess differences by gender. 
Results 
The highest proportions of modifications were seen at the high anterior border and at the high 
lateral part of the CTV (59.9% and 60.7% respectively). The obturator region and posterior border 
were modified in only 27.8% and 27.6% of the cases respectively. Mean modifications (±SD) were 
largest at the ischiorectal fossa, the lower border, the high anterior border and the upper border of 
the CTV (12.5mm (±6.9), 11.9mm (±8.1), 10.6mm (±5.8) and 10.1mm (±7.5), respectively). 
Stratification by gender showed significantly more modifications at the obturator region in males 
compared to females (30.2% vs. 22.8%, p=0.03).  
Conclusion 
Our results highlight ambiguities in current delineation guidelines and stress the need for their 
further improvement. More accurate delineation guidelines for the upper border and for the high 
anterior and high lateral regions will help to decrease the dose to the small bowel. The largest 
modifications at the ischiorectal fossa illustrate the lack of consensus on inclusion of this region in 
the CTV. The difference in anatomy in the lower pelvis between males and females (e.g. narrow male 
pelvis, presence of seminal vesicles) might be the reason for the higher uncertainties in the obturator 
region.   
 
 
 
Table 1: Proportion and extent of modifications per subregion 
Subregion Number of 
modifications (%) 
Mean (SD)  
(mm) 
Min (mm) Max (mm) 10-90 percentile (mm) 
Upper border 372/896 (41.5) 10.1 (7.5) 2.0 68.0 3.0-18.6 
Lower border 355/896 (39.6) 11.9 (8.1) 2.0 48.0 3.0-22.0 
High anterior region 537/896 (59.9) 10.6 (5.8) 2.0 41.5 4.4-18.8 
Low anterior region 398/896 (44.4) 6.9 (4.3) 1.8 26.7 2.9-12.3 
Posterior region 247/896 (27.6) 6.2 (3.2) 1.8 19.0 2.9-10.9 
High lateral region 544/896 (60.7) 8.2 (4.3) 2.0 77.7 4.4-12.2 
Ischiorectal fossa 420/896 (46.9) 12.5 (6.9) 1.9 38.7 4.6-21.5 
Obturator region 249/896 (27.8) 6.0 (2.4) 2.0 16.3 3.3-8.6 
SD=standard deviation      
 
 
 
